W Now, WSW Go - Annals of Internal Medicine - Am Coll Physicians Cardiovascular disease mortality continues to decline, but patients with left
ventricular dysfunction, espe- cially if it results from coronary artery
disease, remain at high risk for both sudden and nonsudden death (1–4). ... Related articles
AE Buxton, KE Ellison, MM Kirk, B Frain, C … - Journal of Interventional Cardiac Electrophysiology, 2003 - Springer Abstract. Over the past decade, four randomized, con- trolled trials have
evaluated therapies for prevention of sudden cardiac death in patients with
coronary disease. Three of the four trials have shown significant reduc- ... Cited by 6 - Related articles - BL Direct - All 4 versions
- ►shouxi.net AE Buxton - The New England journal of medicine, 2005 - nejm.highwire.org The type of arrhythmia observed depends on the temporal relation to myocardial
infarction. In the acute phase of myocardial infarction, the metabolic
consequences of severe ischemia may trigger ventricular fibrillation, even ... Cited by 18 - Related articles - All 7 versions
AJ Moss - tape.com.tr Clinical Implications of the MADIT-II Trial 57 F^atients with coronary heart
disease die "either from progressive heart failure or from a cardiac arrhythmia,
mostly ventricular fibrillation. The available data sug- gest that sudden ... Related articles
AJ Moss - ACC Current Journal Review, 2003 - Elsevier The implantable cardioverter-defibrillator (ICD) was introduced in 1980 to
prevent sudden death in high-risk patients with cardiac disease who had failed
medical therapy. Several randomized clinical trials comparing ICD therapy ... Related articles - All 3 versions
SM Greenberg, AE Epstein, T Deering, DS … - Pacing Clin Electrophysiol, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 12 - Related articles - BL Direct - All 4 versions
AE Buxton - Implantable cardiac pacemakers and defibrillators: all …, 2006 - books.google.com CHAPTERS Indications for the implanted cardio verter-defibrillator Alfred E.
Buxton The implantable defibrillator was introduced to clinical medicine in
1980.1 This device, invented by Michel Mirowski, has revolutionized the ... Related articles - All 2 versions
AJ Moss - Annals of noninvasive electrocardiology: the official …, 2002 - ncbi.nlm.nih.gov 1: Ann Noninvasive Electrocardiol. 2002 Jul;7(3):179-80. MADIT-II and implications
for noninvasive electrophysiologic testing. Moss AJ. ... Cited by 6 - Related articles - BL Direct - All 2 versions
- ►oxfordjournals.org AJ Moss - European heart journal, 2003 - Eur Soc Cardiology Prior to the start-up of MADIT-II, three randomized, placebo-controlled,
clinical trials showed that amiodarone was not effective in reducingall-cause
mortality in patients with coronary disease and varying degrees of left ... Cited by 33 - Related articles - BL Direct - All 3 versions
AJ MOSS - Journal of cardiovascular electrophysiology, 2003 - clinicasaadi.com.br MADIT-I and MADIT-II.The MADIT-I study was a proof-of-principle study, and this
randomized trial showed that the implantable cardioverter defibrillator (ICD)
saves lives in high-risk patients with coronary heart disease. The MADIT-II ... Cited by 23 - Related articles - BL Direct - All 6 versions
